Published by Josh White on 31st December 2024
(Sharecast News) - Haleon announced on Tuesday that it has finalised the acquisition of an additional 33% equity stake in its Chinese joint venture, Tianjin TSKF Pharmaceutical Co (TSKF), from Tianjin Pharmaceutical Group and Tianjin Pharmaceutical Da Ren Tang Group Corporation.
URL: http://www.digitallook.com/dl/news/story/34784223/...